Results for tag: "Nilutamide"

Nilutamide is a nonsteroidal antiandrogen (NSAA) used in the treatment of prostate cancer. It is a synthetic analogue of flutamide, and is used in combination with a luteinizing hormone-releasing hormone (LHRH) agonist to treat advanced prostate cancer. Nilutamide works by blocking the action of androgens, such as testosterone, which can stimulate the growth of prostate cancer cells. It is typically used in combination with other treatments, such as surgery or radiation therapy. Nilutamide is available in both oral and injectable forms, and is typically prescribed for a period of three to six months. Common side effects of nilutamide include nausea, vomiting, diarrhea, and abdominal pain. Other side effects may include headache, dizziness, and fatigue. Nilutamide is a widely used treatment for prostate cancer, and is available from a number of pharmaceutical companies. Some of the companies in the market include AstraZeneca, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more